Comprehensive Cancer Care Department
Address: | Žlutý kopec 534/7, 656 53 Brno, Švejda Pavilion |
---|
phone: | +420 543 132 450 |
---|---|
e-mail: |
Total number of publications: 46
Articles
-
Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy
Targeted Oncology, year: 2024, volume: 19, edition: 2, DOI
-
Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome
NPJ PRECISION ONCOLOGY, year: 2024, volume: 8, edition: 1, DOI
-
Prediktory udržení motivace k pohybu u žen s karcinomem prsu: předběžné výsledky kvalitativní studie
Časopis Klinická onkologie, year: 2024, edition: 37(Suppl 1), DOI
-
Přehled difuzních gliomů dle klasifikace WHO 2021, 2. část - difuzní gliomy dětského typu
Česká a slovenská neurologie a neurochirurgie, year: 2024, volume: 87, edition: 1, DOI
-
Překážky a podpůrné faktory při zapojení onkologických pacientů do programu pohybové aktivity- literární přehled
Klinicka Onkologie, year: 2024, volume: 37, edition: 3, DOI
-
Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1)
Targeted Oncology, year: 2024, DOI
-
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations
Cancer immunology, immunotherapy, year: 2024, volume: 73, edition: 8, DOI
-
Systemic Therapy of Gastric Cancer-State of the Art and Future Perspectives
Cancers, year: 2024, volume: 16, edition: 19, DOI
-
The Impact of Supervised and Home Exercise Activity Intervention on Circulating Immune Cell Numbers in Cancer Patients.
HELIYON, year: 2024, DOI
-
The outcome in patients with BRAF-mutated metastatic melanoma treated with anti-programmed death receptor-1 monotherapy or targeted therapy in the real-world setting
Cancer Medicine, year: 2024, volume: 13, edition: 5, DOI